Global Bladder Cancer Targeted Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 88

Published Date: 06 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

Bladder cancer is a disease in which malignant (cancer) cells form in the tissues of the bladder. Targeted therapy is a treatment that targets the cancer’s specific genes, proteins, or the tissue environment that contributes to cancer growth and survival. This type of treatment blocks the growth and spread of cancer cells and tries to limit damage to healthy cells.

According to our (Global Info Research) latest study, the global Bladder Cancer Targeted Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Bladder Cancer Targeted Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Bladder Cancer Targeted Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Bladder Cancer Targeted Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Bladder Cancer Targeted Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Bladder Cancer Targeted Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Bladder Cancer Targeted Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Bladder Cancer Targeted Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Merck KGaA, Roche, Astellas and Janssen Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
Bladder Cancer Targeted Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Atezolizumab (Tecentriq)
    Avelumab (Bavencio)
    Erdafitinib (Balversa)
    Other

Market segment by Application
    Hospital
    Retail Pharmacy
    Other

Market segment by players, this report covers
    Pfizer
    Merck KGaA
    Roche
    Astellas
    Janssen Biotech
    Bristol-Myers Squibb
    Merck & Co.
    Gilead Sciences

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Bladder Cancer Targeted Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Bladder Cancer Targeted Drug, with revenue, gross margin and global market share of Bladder Cancer Targeted Drug from 2018 to 2023.
Chapter 3, the Bladder Cancer Targeted Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Bladder Cancer Targeted Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Bladder Cancer Targeted Drug.
Chapter 13, to describe Bladder Cancer Targeted Drug research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Bladder Cancer Targeted Drug
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Bladder Cancer Targeted Drug by Type
        1.3.1 Overview: Global Bladder Cancer Targeted Drug Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global Bladder Cancer Targeted Drug Consumption Value Market Share by Type in 2022
        1.3.3 Atezolizumab (Tecentriq)
        1.3.4 Avelumab (Bavencio)
        1.3.5 Erdafitinib (Balversa)
        1.3.6 Other
    1.4 Global Bladder Cancer Targeted Drug Market by Application
        1.4.1 Overview: Global Bladder Cancer Targeted Drug Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospital
        1.4.3 Retail Pharmacy
        1.4.4 Other
    1.5 Global Bladder Cancer Targeted Drug Market Size & Forecast
    1.6 Global Bladder Cancer Targeted Drug Market Size and Forecast by Region
        1.6.1 Global Bladder Cancer Targeted Drug Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global Bladder Cancer Targeted Drug Market Size by Region, (2018-2029)
        1.6.3 North America Bladder Cancer Targeted Drug Market Size and Prospect (2018-2029)
        1.6.4 Europe Bladder Cancer Targeted Drug Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific Bladder Cancer Targeted Drug Market Size and Prospect (2018-2029)
        1.6.6 South America Bladder Cancer Targeted Drug Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa Bladder Cancer Targeted Drug Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Pfizer
        2.1.1 Pfizer Details
        2.1.2 Pfizer Major Business
        2.1.3 Pfizer Bladder Cancer Targeted Drug Product and Solutions
        2.1.4 Pfizer Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Pfizer Recent Developments and Future Plans
    2.2 Merck KGaA
        2.2.1 Merck KGaA Details
        2.2.2 Merck KGaA Major Business
        2.2.3 Merck KGaA Bladder Cancer Targeted Drug Product and Solutions
        2.2.4 Merck KGaA Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Merck KGaA Recent Developments and Future Plans
    2.3 Roche
        2.3.1 Roche Details
        2.3.2 Roche Major Business
        2.3.3 Roche Bladder Cancer Targeted Drug Product and Solutions
        2.3.4 Roche Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Roche Recent Developments and Future Plans
    2.4 Astellas
        2.4.1 Astellas Details
        2.4.2 Astellas Major Business
        2.4.3 Astellas Bladder Cancer Targeted Drug Product and Solutions
        2.4.4 Astellas Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Astellas Recent Developments and Future Plans
    2.5 Janssen Biotech
        2.5.1 Janssen Biotech Details
        2.5.2 Janssen Biotech Major Business
        2.5.3 Janssen Biotech Bladder Cancer Targeted Drug Product and Solutions
        2.5.4 Janssen Biotech Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 Janssen Biotech Recent Developments and Future Plans
    2.6 Bristol-Myers Squibb
        2.6.1 Bristol-Myers Squibb Details
        2.6.2 Bristol-Myers Squibb Major Business
        2.6.3 Bristol-Myers Squibb Bladder Cancer Targeted Drug Product and Solutions
        2.6.4 Bristol-Myers Squibb Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
    2.7 Merck & Co.
        2.7.1 Merck & Co. Details
        2.7.2 Merck & Co. Major Business
        2.7.3 Merck & Co. Bladder Cancer Targeted Drug Product and Solutions
        2.7.4 Merck & Co. Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Merck & Co. Recent Developments and Future Plans
    2.8 Gilead Sciences
        2.8.1 Gilead Sciences Details
        2.8.2 Gilead Sciences Major Business
        2.8.3 Gilead Sciences Bladder Cancer Targeted Drug Product and Solutions
        2.8.4 Gilead Sciences Bladder Cancer Targeted Drug Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 Gilead Sciences Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Bladder Cancer Targeted Drug Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of Bladder Cancer Targeted Drug by Company Revenue
        3.2.2 Top 3 Bladder Cancer Targeted Drug Players Market Share in 2022
        3.2.3 Top 6 Bladder Cancer Targeted Drug Players Market Share in 2022
    3.3 Bladder Cancer Targeted Drug Market: Overall Company Footprint Analysis
        3.3.1 Bladder Cancer Targeted Drug Market: Region Footprint
        3.3.2 Bladder Cancer Targeted Drug Market: Company Product Type Footprint
        3.3.3 Bladder Cancer Targeted Drug Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Bladder Cancer Targeted Drug Consumption Value and Market Share by Type (2018-2023)
    4.2 Global Bladder Cancer Targeted Drug Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2018-2023)
    5.2 Global Bladder Cancer Targeted Drug Market Forecast by Application (2024-2029)

6 North America
    6.1 North America Bladder Cancer Targeted Drug Consumption Value by Type (2018-2029)
    6.2 North America Bladder Cancer Targeted Drug Consumption Value by Application (2018-2029)
    6.3 North America Bladder Cancer Targeted Drug Market Size by Country
        6.3.1 North America Bladder Cancer Targeted Drug Consumption Value by Country (2018-2029)
        6.3.2 United States Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        6.3.3 Canada Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        6.3.4 Mexico Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe Bladder Cancer Targeted Drug Consumption Value by Type (2018-2029)
    7.2 Europe Bladder Cancer Targeted Drug Consumption Value by Application (2018-2029)
    7.3 Europe Bladder Cancer Targeted Drug Market Size by Country
        7.3.1 Europe Bladder Cancer Targeted Drug Consumption Value by Country (2018-2029)
        7.3.2 Germany Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        7.3.3 France Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        7.3.5 Russia Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        7.3.6 Italy Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific Bladder Cancer Targeted Drug Market Size by Region
        8.3.1 Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Region (2018-2029)
        8.3.2 China Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        8.3.3 Japan Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        8.3.4 South Korea Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        8.3.5 India Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        8.3.7 Australia Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)

9 South America
    9.1 South America Bladder Cancer Targeted Drug Consumption Value by Type (2018-2029)
    9.2 South America Bladder Cancer Targeted Drug Consumption Value by Application (2018-2029)
    9.3 South America Bladder Cancer Targeted Drug Market Size by Country
        9.3.1 South America Bladder Cancer Targeted Drug Consumption Value by Country (2018-2029)
        9.3.2 Brazil Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        9.3.3 Argentina Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa Bladder Cancer Targeted Drug Market Size by Country
        10.3.1 Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Country (2018-2029)
        10.3.2 Turkey Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)
        10.3.4 UAE Bladder Cancer Targeted Drug Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 Bladder Cancer Targeted Drug Market Drivers
    11.2 Bladder Cancer Targeted Drug Market Restraints
    11.3 Bladder Cancer Targeted Drug Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 Bladder Cancer Targeted Drug Industry Chain
    12.2 Bladder Cancer Targeted Drug Upstream Analysis
    12.3 Bladder Cancer Targeted Drug Midstream Analysis
    12.4 Bladder Cancer Targeted Drug Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Bladder Cancer Targeted Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global Bladder Cancer Targeted Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global Bladder Cancer Targeted Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global Bladder Cancer Targeted Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Pfizer Company Information, Head Office, and Major Competitors
    Table 6. Pfizer Major Business
    Table 7. Pfizer Bladder Cancer Targeted Drug Product and Solutions
    Table 8. Pfizer Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Pfizer Recent Developments and Future Plans
    Table 10. Merck KGaA Company Information, Head Office, and Major Competitors
    Table 11. Merck KGaA Major Business
    Table 12. Merck KGaA Bladder Cancer Targeted Drug Product and Solutions
    Table 13. Merck KGaA Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Merck KGaA Recent Developments and Future Plans
    Table 15. Roche Company Information, Head Office, and Major Competitors
    Table 16. Roche Major Business
    Table 17. Roche Bladder Cancer Targeted Drug Product and Solutions
    Table 18. Roche Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Roche Recent Developments and Future Plans
    Table 20. Astellas Company Information, Head Office, and Major Competitors
    Table 21. Astellas Major Business
    Table 22. Astellas Bladder Cancer Targeted Drug Product and Solutions
    Table 23. Astellas Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Astellas Recent Developments and Future Plans
    Table 25. Janssen Biotech Company Information, Head Office, and Major Competitors
    Table 26. Janssen Biotech Major Business
    Table 27. Janssen Biotech Bladder Cancer Targeted Drug Product and Solutions
    Table 28. Janssen Biotech Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. Janssen Biotech Recent Developments and Future Plans
    Table 30. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
    Table 31. Bristol-Myers Squibb Major Business
    Table 32. Bristol-Myers Squibb Bladder Cancer Targeted Drug Product and Solutions
    Table 33. Bristol-Myers Squibb Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Bristol-Myers Squibb Recent Developments and Future Plans
    Table 35. Merck & Co. Company Information, Head Office, and Major Competitors
    Table 36. Merck & Co. Major Business
    Table 37. Merck & Co. Bladder Cancer Targeted Drug Product and Solutions
    Table 38. Merck & Co. Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Merck & Co. Recent Developments and Future Plans
    Table 40. Gilead Sciences Company Information, Head Office, and Major Competitors
    Table 41. Gilead Sciences Major Business
    Table 42. Gilead Sciences Bladder Cancer Targeted Drug Product and Solutions
    Table 43. Gilead Sciences Bladder Cancer Targeted Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. Gilead Sciences Recent Developments and Future Plans
    Table 45. Global Bladder Cancer Targeted Drug Revenue (USD Million) by Players (2018-2023)
    Table 46. Global Bladder Cancer Targeted Drug Revenue Share by Players (2018-2023)
    Table 47. Breakdown of Bladder Cancer Targeted Drug by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 48. Market Position of Players in Bladder Cancer Targeted Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 49. Head Office of Key Bladder Cancer Targeted Drug Players
    Table 50. Bladder Cancer Targeted Drug Market: Company Product Type Footprint
    Table 51. Bladder Cancer Targeted Drug Market: Company Product Application Footprint
    Table 52. Bladder Cancer Targeted Drug New Market Entrants and Barriers to Market Entry
    Table 53. Bladder Cancer Targeted Drug Mergers, Acquisition, Agreements, and Collaborations
    Table 54. Global Bladder Cancer Targeted Drug Consumption Value (USD Million) by Type (2018-2023)
    Table 55. Global Bladder Cancer Targeted Drug Consumption Value Share by Type (2018-2023)
    Table 56. Global Bladder Cancer Targeted Drug Consumption Value Forecast by Type (2024-2029)
    Table 57. Global Bladder Cancer Targeted Drug Consumption Value by Application (2018-2023)
    Table 58. Global Bladder Cancer Targeted Drug Consumption Value Forecast by Application (2024-2029)
    Table 59. North America Bladder Cancer Targeted Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 60. North America Bladder Cancer Targeted Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 61. North America Bladder Cancer Targeted Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 62. North America Bladder Cancer Targeted Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 63. North America Bladder Cancer Targeted Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 64. North America Bladder Cancer Targeted Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 65. Europe Bladder Cancer Targeted Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 66. Europe Bladder Cancer Targeted Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 67. Europe Bladder Cancer Targeted Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 68. Europe Bladder Cancer Targeted Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 69. Europe Bladder Cancer Targeted Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 70. Europe Bladder Cancer Targeted Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 71. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 72. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 73. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 74. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 75. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Region (2018-2023) & (USD Million)
    Table 76. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value by Region (2024-2029) & (USD Million)
    Table 77. South America Bladder Cancer Targeted Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 78. South America Bladder Cancer Targeted Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 79. South America Bladder Cancer Targeted Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 80. South America Bladder Cancer Targeted Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 81. South America Bladder Cancer Targeted Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 82. South America Bladder Cancer Targeted Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 83. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Type (2018-2023) & (USD Million)
    Table 84. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Type (2024-2029) & (USD Million)
    Table 85. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Application (2018-2023) & (USD Million)
    Table 86. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Application (2024-2029) & (USD Million)
    Table 87. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Country (2018-2023) & (USD Million)
    Table 88. Middle East & Africa Bladder Cancer Targeted Drug Consumption Value by Country (2024-2029) & (USD Million)
    Table 89. Bladder Cancer Targeted Drug Raw Material
    Table 90. Key Suppliers of Bladder Cancer Targeted Drug Raw Materials
List of Figures
    Figure 1. Bladder Cancer Targeted Drug Picture
    Figure 2. Global Bladder Cancer Targeted Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global Bladder Cancer Targeted Drug Consumption Value Market Share by Type in 2022
    Figure 4. Atezolizumab (Tecentriq)
    Figure 5. Avelumab (Bavencio)
    Figure 6. Erdafitinib (Balversa)
    Figure 7. Other
    Figure 8. Global Bladder Cancer Targeted Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 9. Bladder Cancer Targeted Drug Consumption Value Market Share by Application in 2022
    Figure 10. Hospital Picture
    Figure 11. Retail Pharmacy Picture
    Figure 12. Other Picture
    Figure 13. Global Bladder Cancer Targeted Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global Bladder Cancer Targeted Drug Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market Bladder Cancer Targeted Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global Bladder Cancer Targeted Drug Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global Bladder Cancer Targeted Drug Consumption Value Market Share by Region in 2022
    Figure 18. North America Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global Bladder Cancer Targeted Drug Revenue Share by Players in 2022
    Figure 24. Bladder Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players Bladder Cancer Targeted Drug Market Share in 2022
    Figure 26. Global Top 6 Players Bladder Cancer Targeted Drug Market Share in 2022
    Figure 27. Global Bladder Cancer Targeted Drug Consumption Value Share by Type (2018-2023)
    Figure 28. Global Bladder Cancer Targeted Drug Market Share Forecast by Type (2024-2029)
    Figure 29. Global Bladder Cancer Targeted Drug Consumption Value Share by Application (2018-2023)
    Figure 30. Global Bladder Cancer Targeted Drug Market Share Forecast by Application (2024-2029)
    Figure 31. North America Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 41. France Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific Bladder Cancer Targeted Drug Consumption Value Market Share by Region (2018-2029)
    Figure 48. China Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 51. India Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa Bladder Cancer Targeted Drug Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa Bladder Cancer Targeted Drug Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa Bladder Cancer Targeted Drug Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE Bladder Cancer Targeted Drug Consumption Value (2018-2029) & (USD Million)
    Figure 65. Bladder Cancer Targeted Drug Market Drivers
    Figure 66. Bladder Cancer Targeted Drug Market Restraints
    Figure 67. Bladder Cancer Targeted Drug Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of Bladder Cancer Targeted Drug in 2022
    Figure 70. Manufacturing Process Analysis of Bladder Cancer Targeted Drug
    Figure 71. Bladder Cancer Targeted Drug Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2023-2029

Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2023-2029

date 03 Feb 2023

date Pharma & Healthcare

The global Bladder Cancer Targeted Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

Global Bladder Cancer Targeted Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Bladder Cancer Targeted Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 05 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Bladder Cancer Targeted Drug market size was valued at USD 779.9 million in 2023 and is forecast to a readjusted size of USD 1408 million by 2030 with a CAGR of 8.8% during review period.

Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2024-2030

Global Bladder Cancer Targeted Drug Supply, Demand and Key Producers, 2024-2030

date 24 Feb 2024

date Pharma & Healthcare

The global Bladder Cancer Targeted Drug market size is expected to reach $ 1408 million by 2030, rising at a market growth of 8.8% CAGR during the forecast period (2024-2030).

Global Bladder Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Global Bladder Cancer Targeted Drug Market 2025 by Company, Regions, Type and Application, Forecast to 2031

date 13 Jan 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Bladder Cancer Targeted Drug market size was valued at US$ 929 million in 2024 and is forecast to a readjusted size of USD 1686 million by 2031 with a CAGR of 9.0% during review period.

Product Tags

Bladder Cancer Targeted Drug

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>